HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Infantile neuroaxonal dystrophy caused by uniparental disomy.

Abstract
Infantile neuroaxonal dystrophy (INAD) is a rare autosomal recessive neurodegenerative disorder caused by mutations in the phospholipase A2 group 6 (Pla2G6) gene. Affected individuals usually present between the ages of 6 months and 2 years with rapid cognitive and motor regression and axial hypotonia. Gait disturbance, limb spasticity, cerebellar signs, and optic atrophy are other common features associated with INAD. Although magnetic resonance imaging (MRI) can sometimes contribute towards the diagnosis, the confirmation of INAD is by Pla2G6 gene analysis. In this case report, we describe the first individual (female) with INAD due to a combination of uniparental heterodisomy and isodisomy; we discuss the possible underlying mechanism and highlight the importance of parental carrier testing in accurately predicting the recurrence risk in these families. We also confirm the recent report of hypertrophy of the clava (also known as the 'gracile tubercle') as a useful MRI sign in INAD.
AuthorsJoyce Solomons, Oliver Ridgway, Carol Hardy, Manju A Kurian, Manju Kurian, Sandeep Jayawant, Sarah Hughes, Pieter Pretorius, Andrea H Németh
JournalDevelopmental medicine and child neurology (Dev Med Child Neurol) Vol. 56 Issue 4 Pg. 386-9 (Apr 2014) ISSN: 1469-8749 [Electronic] England
PMID24628589 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 Mac Keith Press.
Chemical References
  • Group VI Phospholipases A2
  • PLA2G6 protein, human
Topics
  • Female
  • Group VI Phospholipases A2 (genetics)
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Neuroaxonal Dystrophies (genetics)
  • Uniparental Disomy (genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: